```html

Jellyfish‑Induced Anaphylaxis: A Complete Medical Guide

Overview

Jellyfish‑induced anaphylaxis is a rare, potentially life‑threatening allergic reaction that occurs after contact with certain jellyfish species. While most jellyfish stings cause localized pain, swelling, and skin irritation, a small subset of individuals experience a systemic hypersensitivity response that can progress rapidly to anaphylaxis.

Who it affects: Anyone who is sensitized to jellyfish venom can develop anaphylaxis, but the risk is higher in people with a prior history of severe allergic reactions (e.g., to food, insect stings, or medications), those who have been stung repeatedly, and individuals with underlying mast‑cell disorders.

Prevalence: Worldwide, an estimated 0.4–2.5 % of people who are stung by highly venomous jellyfish (such as the box jellyfish Chironex fleckeri or the Portuguese man‑of‑war Physalia physalis) develop systemic reactions, and among those, true anaphylaxis occurs in less than 0.1 % of stings <sup>CDC</sup>. In Australia, where box jellyfish are endemic, there are roughly 30–40 reported anaphylactic cases per year, with a mortality rate of 5–15 % if treatment is delayed <sup>Mayo Clinic</sup>.

Symptoms

Anaphylaxis is a multi‑system reaction that typically develops within minutes of exposure but can be delayed up to several hours. The following symptoms may appear alone or in combination:

Cutaneous (skin)

• Urticaria (hives): Raised, itchy wheals that may spread rapidly.
• Flushing or erythema: Redness of the face, neck, or trunk.
• Angio‑edema: Swelling of the lips, tongue, or around the eyes.

Respiratory

• Difficulty breathing or wheezing.
• Throat tightness or a sensation of “food stuck” in the throat.
• Hoarseness, cough, or noisy breathing (stridor).
• Rapid, shallow breathing (tachypnea).

Cardiovascular

• Drop in blood pressure (hypotension) leading to dizziness or fainting.
• Rapid heart rate (tachycardia) or, paradoxically, a slow heart rate (bradycardia) in severe cases.
• Chest pain or a feeling of impending doom.

Gastrointestinal

• Nausea, vomiting, or abdominal cramping.
• Diarrhea.

Neurologic

• Light‑headedness, confusion, or loss of consciousness.
• Feeling of anxiety or panic.

Because jellyfish venom itself can cause pain, burning, and skin necrosis, it may be difficult to distinguish a severe local reaction from an early systemic allergic response. Any rapid spread of symptoms beyond the sting site warrants immediate medical evaluation.

Causes and Risk Factors

What causes jellyfish‑induced anaphylaxis?

Jellyfish carry complex mixtures of neurotoxins, proteolytic enzymes, and allergenic proteins in their nematocysts (stinging cells). In most people, venom causes a localized inflammatory reaction. In sensitized individuals, the immune system mistakenly identifies specific venom proteins as harmful, producing IgE antibodies. Subsequent exposure triggers massive mast‑cell and basophil degranulation, releasing histamine, leukotrienes, and other mediators that drive the systemic anaphylactic cascade.

Key risk factors

• Previous severe allergic reactions: Prior anaphylaxis to food, bee/wasp stings, or medications raises suspicion for cross‑reactivity.
• Multiple or recent jellyfish stings: Repeated exposure can sensitize the immune system.
• Pre‑existing mast‑cell disorders: Conditions such as mastocytosis increase baseline mediator release.
• Age: Children and adolescents tend to have more robust IgE responses, although adults can be affected.
• Geographic exposure: Living in or traveling to regions with highly venomous species (e.g., Indo‑Pacific box jellyfish, Atlantic Portuguese man‑of‑war).
• Medication use: Beta‑blockers and ACE inhibitors may blunt the response to epinephrine, worsening outcomes.

Diagnosis

Diagnosis is primarily clinical, based on rapid recognition of the symptom pattern after a known jellyfish sting. However, supporting investigations help confirm anaphylaxis, assess severity, and rule out other conditions.

Clinical criteria (World Allergy Organization)

• Acute onset (minutes to 1 hour) of skin/mucosal involvement plus either respiratory compromise or reduced blood pressure.
• Two or more of the following after exposure to a likely allergen: skin involvement, respiratory symptoms, gastrointestinal symptoms, or cardiovascular collapse.

Laboratory tests

• Serum tryptase: Elevated >1 hour after symptom onset suggests mast‑cell activation.
• Total IgE and specific IgE to jellyfish venom: Available in specialized allergy labs; useful for long‑term risk assessment.
• Complete blood count (CBC): May show eosinophilia in chronic sensitization.
• Blood pressure & pulse oximetry: Continuous monitoring is essential during acute care.

Skin testing & provocation

In a controlled allergy clinic, a diluted venom extract can be used for skin prick testing. Positive results confirm sensitization but do not predict reaction severity. Oral or cutaneous provocation tests are rarely performed due to risk.

Treatment Options

Time is critical. The cornerstone of therapy is immediate intramuscular epinephrine, followed by supportive measures.

First‑line emergency treatment

• Epinephrine (adrenaline): 0.3 mg (1:1000) intramuscularly into the anterolateral thigh. Repeat every 5–15 minutes if symptoms persist.
• Positioning: Lay the patient supine with legs elevated unless respiratory distress mandates a sitting position.
• High‑flow oxygen: 10–15 L/min via non‑rebreather mask.
• Airway management: Rapid assessment; be prepared for endotracheal intubation if airway edema progresses.

Adjunctive medications

• Antihistamines: H1 blocker (e.g., diphenhydramine 25–50 mg IV/IM) for cutaneous symptoms; H2 blocker (e.g., ranitidine 50 mg IV) can be added.
• Corticosteroids: Methylprednisolone 1–2 mg/kg IV; useful for preventing biphasic reactions, though they do not treat acute airway obstruction.
• Bronchodilators: Albuterol nebulization for bronchospasm.
• IV Fluids: Crystalloid bolus (20 mL/kg) for hypotension.

Observation

Patients should be monitored for at least 4–6 hours after symptom resolution, longer (up to 24 hours) if they received multiple epinephrine doses, have a history of biphasic reactions, or are pregnant.

Long‑term preventive measures

• Epinephrine auto‑injector prescription: Carry two devices (e.g., EpiPen, Auvi‑Q) and know how to use them.
• Allergy referral: Formal evaluation by an allergist/immunologist for venom‑specific IgE testing and an individualized emergency action plan.
• Medical alert identification: Wear a bracelet or necklace indicating “Jellyfish venom allergy.”

Living with Jellyfish‑Induced Anaphylaxis

Managing this condition is a blend of medical preparedness and lifestyle adjustments.

Daily management tips

• Keep auto‑injectors in a cool, accessible place; replace them before the expiration date.
• Educate family, friends, coworkers, and travel companions on how and when to use epinephrine.
• Maintain an up‑to‑date emergency action plan and review it annually with your allergist.
• Carry a small first‑aid kit that includes antihistamine tablets, a copy of your allergy documentation, and a waterproof pouch for the auto‑injector.
• Wear protective clothing (e.g., full‑body wetsuits, stinger‑proof swim leggings) when swimming in high‑risk waters.
• Drink plenty of water and avoid alcohol before beach activities; dehydration can exacerbate hypotension during an reaction.

Psychological aspects

Fear of a severe reaction can limit recreational activities. Cognitive‑behavioral therapy (CBT) and support groups have been shown to improve confidence and quality of life in patients with severe allergy syndromes <sup>Cleveland Clinic</sup>.

Prevention

Because avoidance is the most effective strategy, focus on environmental and behavioral measures.

• Stay informed: Review local marine‑life warnings; many beaches post jellyfish advisories during bloom seasons.
• Protective gear: Use stinger‑proof “jellyfish suits” or thick neoprene wetsuits that cover the entire body.
• Vinegar stations: In some regions, first‑aid stations provide 4 % acetic acid solution, which can neutralize unfired nematocysts on the skin (does not treat systemic allergy).
• Shower promptly: After water exposure, rinse with seawater (not fresh water) to prevent nematocyst discharge, then follow with vinegar if available.
• Avoid peak times: Jellyfish are most abundant at dusk, during high tides, and after heavy rains.
• Travel precautions: If you have a known jellyfish allergy, consider purchasing travel insurance that covers emergency evacuation from remote islands.

Complications

If anaphylaxis is not recognized or treated promptly, the following complications may arise:

• Respiratory failure: Due to airway edema, bronchospasm, or laryngeal obstruction.
• Cardiogenic or hypovolemic shock: Resulting from severe vasodilation and plasma leakage.
• Neurological injury: Hypoxic brain injury secondary to prolonged hypotension.
• Biphasic reaction: Recurrence of symptoms 4–12 hours after the initial event, occurring in up to 20 % of anaphylaxis cases <sup>NIH</sup>.
• Secondary infection: Local necrotic skin lesions from jellyfish venom can become infected if not properly cleaned.
• Psychological trauma: Post‑traumatic stress disorder (PTSD) or anxiety after a severe reaction.

When to Seek Emergency Care

Call 911 (or your local emergency number) immediately if you experience any of the following after a jellyfish sting:

• Difficulty breathing, wheezing, or throat tightness.
• Swelling of the lips, tongue, or face that makes swallowing or speaking hard.
• Sudden drop in blood pressure (feeling faint, dizziness, or loss of consciousness).
• Rapid, weak pulse or heart palpitations.
• Severe abdominal pain, persistent vomiting, or diarrhea.
• Hives that cover a large area of the body or spread quickly.
• Any signs of a secondary reaction after a first‑dose of epinephrine (e.g., symptoms return within 30 minutes).

If you have an epinephrine auto‑injector, administer it right away while waiting for EMS. Do not delay for transport.

References

1. Mayo Clinic. Anaphylaxis – Symptoms and causes. Updated 2023.
2. Centers for Disease Control and Prevention (CDC). Jellyfish Stings and Marine Envenomation. 2022.
3. World Allergy Organization. Anaphylaxis Guidelines. 2020.
4. National Institutes of Health (NIH). Biphasic Anaphylaxis: Incidence and Management. 2021.
5. Cleveland Clinic. Anaphylaxis: Diagnosis and Treatment. 2024.
6. World Health Organization (WHO). Marine Envenomation Surveillance. 2023.

```